{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:44:32Z","timestamp":1696355072386},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.medcli.2015.10.008","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T22:01:59Z","timestamp":1449093719000},"page":"376-377","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ivermectina subcut\u00e1nea en estrongiloidiasis diseminada: a prop\u00f3sito de la autorizaci\u00f3n de un medicamento veterinario para uso humano"],"prefix":"10.1016","volume":"146","author":[{"given":"Silvia","family":"Manrique-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Mart\u00edn-Rabad\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"D\u00edaz-C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia M.","family":"Fern\u00e1ndez-Llamazares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2015.10.008_bib0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bjid.2012.08.008","article-title":"Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: Therapy success with subcutaneous ivermectin","volume":"16","author":"Moura","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.medcli.2015.10.008_bib0060","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pntd.0001044","article-title":"Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis","volume":"5","author":"Suputtamongkol","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.medcli.2015.10.008_bib0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/00365540903443165","article-title":"Serum ivermectin levels after enteral and subcutaneous administration for strongyloides hyperinfection: A case report","volume":"42","author":"Grein","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medcli.2015.10.008_bib0070","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Medicamentos en situaciones especiales. Instrucciones para la tramitaci\u00f3n de solicitudes [citada 10 Jul 2015]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/medSituacionesEspeciales\/instruccTramitacion.htm"},{"key":"10.1016\/j.medcli.2015.10.008_bib0075","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Medicamentos veterinarios autorizados [citada 10 Jul 2015]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosVeterinarios\/Med-Vet-autorizados\/home.htm"},{"key":"10.1016\/j.medcli.2015.10.008_bib0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eimc.2014.06.010","article-title":"Strongyloidiasis in immigrants in southern Spain","volume":"33","author":"Cabezas-Fernandez","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.medcli.2015.10.008_bib0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijantimicag.2013.07.015","article-title":"Strongyloides disseminated infection successfully treated with parenteral ivermectin: Case report with drug concentration measurements and review of the literature","volume":"42","author":"Donadello","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medcli.2015.10.008_bib0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4269\/ajtmh.2010.10-0258","article-title":"Non-oral treatment with ivermectin for disseminated strongyloidiasis","volume":"83","author":"Fusco","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.medcli.2015.10.008_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)02744-0","article-title":"Parenteral ivermectin in strongyloides hyperinfection","volume":"355","author":"Chiodini","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2015.10.008_bib0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4269\/ajtmh.2005.73.911","article-title":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis","volume":"73","author":"Turner","year":"2005","journal-title":"Am J Trop Med Hyg"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315005771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315005771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:49:07Z","timestamp":1567385347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775315005771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0025775315005771"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2015.10.008","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivermectina subcut\u00e1nea en estrongiloidiasis diseminada: a prop\u00f3sito de la autorizaci\u00f3n de un medicamento veterinario para uso humano","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2015.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}